TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,952 | -66.3% | 353 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $8,769 | +65.1% | 353 | 0.0% | 0.00% | +100.0% |
| Q1 2023 | $5,310 | +27.2% | 353 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $4,176 | +108.8% | 353 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $2,000 | 0.0% | 353 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $2,000 | -33.3% | 353 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $3,000 | -57.1% | 353 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $7,000 | -41.7% | 353 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $12,000 | -14.3% | 353 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $14,000 | -17.6% | 353 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $17,000 | +70.0% | 353 | +81.0% | 0.00% | +33.3% |
| Q4 2020 | $10,000 | +100.0% | 195 | 0.0% | 0.00% | +200.0% |
| Q3 2020 | $5,000 | +25.0% | 195 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $4,000 | +100.0% | 195 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $2,000 | – | 195 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |